Amy Simon
Chief Tech/Sci/R&D Officer at BEAM THERAPEUTICS INC.
Net worth: 2 M $ as of 30/03/2024
Profile
Amy Simon is Chief Medical Officer for Beam Therapeutics, Inc. In the past Dr. Simon held the position of Vice President-Clinical Development at Alnylam Pharmaceuticals, Inc. Dr. Simon received an undergraduate degree from Harvard University and a doctorate from Tufts University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BEAM THERAPEUTICS, INC.
0.09% | 01/04/2024 | 70,060 ( 0.09% ) | 2 M $ | 30/03/2024 |
Amy Simon active positions
| Companies | Position | Start |
|---|---|---|
| BEAM THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 14/03/2021 |
Former positions of Amy Simon
| Companies | Position | End |
|---|---|---|
| Tufts University | Corporate Officer/Principal | - |
| Graduate School of Biomedical Sciences | Corporate Officer/Principal | - |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Training of Amy Simon
| Harvard University | Undergraduate Degree |
| Tufts University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| BEAM THERAPEUTICS INC. | Health Technology |
| Private companies | 1 |
|---|---|
| Graduate School of Biomedical Sciences |
- Stock Market
- Insiders
- Amy Simon
